Article Details
Retrieved on: 2025-09-29 16:05:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
New state-of-the-art active pharmaceutical ingredient (API) facility will manufacture immunology, oncology and neuroscience medicines; Facility ...
Article found on: news.abbvie.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here